This panel delves deep into the world of finance and investment taking a close look at the current macroeconomic conditions and the outlook for small-cap stocks and the broader market in 2024. This Industry Update featured special guests Art Hogan, Managing Director...
Innovating Healthcare: Cutting-Edge Services and Solutions in the Modern Marketplace
This panel explores how innovative technologies, business models, and strategies are reshaping healthcare delivery, improving patient outcomes, and creating exciting #investment opportunities. Speakers include: Dr. Lisa Crossley, CEO at Reliq Health Technologies,...
Fertility Frontiers: Leading Edge Technologies Addressing the Fertility Market KOL Panel
This panel explores the dynamic realm of leading-edge technologies within the fertility market. Speakers include Steve Shum, CEO at INVO Bioscience and David Wolf, CEO at Hamilton Thorne Ltd. This KOL Panel was recorded during the Lytham Partners Fall 2023 Investor...
Target Zero: Eco-Friendly Consumer Products for a Sustainable Future
This panel explores the compelling and rapidly growing world of eco-friendly consumer products. Panelists include Trent MacDonald, CFO at Flow Beverage Corp. and Marc Delcourt, Co-Founder & CEO at Global Bioenergies. This KOL Panel was recorded during the Lytham...
Cardiac Kids: Late-Stage Advancement for Cardiovascular Disorders KOL Panel
In this panel companies discuss developments in the broader market, as well as their unique late-stage drugs looking to address cardiac-based indications. Panelists include Quang Pham, Chairman & CEO at Cadrenal Therapeutics and Craig Fraser, CEO at Windtree...
The State of Animal Health KOL Panel
In this panel we discuss the direction of the animal health industry, primarily on the companion animal side. Independent industry analysts have estimated that the size of the U.S. companion animal health market was valued at approximately $5.2 billion last year in...
Phase 3 Drugs to Watch KOL Panel
This panel presentation features executives from three different companies that are looking to advance innovations in healthcare, each of them with ongoing or planned Phase 3 trials here. We've titled the panel, Phase 3 Drugs to Watch. Hosted by Lytham Partners...
Revolutionizing Healthy Nutrition KOL Panel
In this panel we will be examining the cutting-edge advancements in healthy nutrition as three companies redefine the landscape, from infant nutrition to adult snacking and beyond. Joining us today are Hamutal Yitzhak, Co-Founder and CEO of Else Nutrition, that’s BABY...
Advancements in the Fight Against Cancer KOL Panel
Today's panel will delve into groundbreaking technologies, medical devices and pharmaceuticals in various stages of development to combat cancer. Joining us today are Gerard Michel, CEO of Delcath Technologies, ticker DCTH on the NASDAQ; as well as Dr. Anatoly...
Social Media – Where Do We Go From Here KOL Panel
In this panel we examine the present usage of social media and embark on an exploration of its future implications. Joining us today are Peter Friedman, Chairman, CEO and Founder of LiveWorld, that's ticker LVWD, Larry-Victor-Wisconsin-David; and Eddie Geller, CEO and...